Lessee, Operating Lease, Liability, to be Paid, Year Three of Burning Rock Biotech Ltd from 31 Dec 2021 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD and CNY
Description
Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).
Summary
Burning Rock Biotech Ltd quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in USD history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • Burning Rock Biotech Ltd Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2024 was $1,718,000.
Burning Rock Biotech Ltd quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three in CNY history and change rate from 31 Dec 2021 to 31 Dec 2024.
  • Burning Rock Biotech Ltd Lessee, Operating Lease, Liability, to be Paid, Year Three for the quarter ending 31 Dec 2024 was ¥12,539,000.
Source SEC data
View on sec.gov
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (USD)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)
Lessee, Operating Lease, Liability, to be Paid, Year Three, Quarterly (CNY)
Lessee, Operating Lease, Liability, to be Paid, Year Three, YoY Quarterly Change (%)

Burning Rock Biotech Ltd Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,718,000 31 Dec 2024 20-F 29 Apr 2025 2024 FY
Q4 2022 $543,000 -$820,000 -60% 31 Dec 2022 20-F 20 Apr 2023 2022 FY
Q4 2021 $1,363,000 31 Dec 2021 20-F 29 Apr 2022 2021 FY

Burning Rock Biotech Ltd Quarterly Lessee, Operating Lease, Liability, to be Paid, Year Three (CNY)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 ¥12,539,000 31 Dec 2024 20-F 29 Apr 2025 2024 FY
Q4 2022 ¥3,746,000 -¥4,942,000 -57% 31 Dec 2022 20-F 20 Apr 2023 2022 FY
Q4 2021 ¥8,688,000 31 Dec 2021 20-F 29 Apr 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.